AD-118, AD-1181

DRUG2 trials

Sponsors

Addpharma Inc.

Conditions

Chronic Heart Failure

Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects

Not yet recruitingNCT07476157

Addpharma Inc.Chronic Heart Failure

Start: 2026-04-01End: 2026-05-01Target: 70Updated: 2026-03-17

A Study to Evaluate the Safety, Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects

Not yet recruitingNCT07717749

Addpharma Inc.Chronic Heart Failure

Start: 2026-07-24End: 2026-08-01Target: 74Updated: 2026-07-21